Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.

NCT00324766 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Heart Failure
Cardiogenic Shock

Interventions

DRUG: levosimendan
DRUG: placebo,

Sponsor

Oslo University Hospital